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Terminal deoxynucleotidyl transferase: The story of a misguided DNA polymerase
Edward A. Motea , Anthony J. Berdis
Introduction
DNA polymerases play essential roles in replication, repair, and
recombination of nucleic acid. During each of these biological
processes, the polymerase extends a primer using a DNA (or RNA in
the case of reverse transcription) template to guide each incorpora
tion event. Even during the bypass of lethal forms of DNA damage, the
presence of a templating strand is absolutely essential for polymerase
activity. However, the requirement for using a template is not
universal as there exists a unique enzyme, denoted as terminal
deoxynucleotidyl transferase (TdT), that possesses the unusual ability
to incorporate nucleotides in a template independent manner using
only single stranded DNA as the nucleic acid substrate [1,2] (Fig. 1). The
unique ability of TdT to create genomic material de novomakes it one
of the most fascinating DNA polymerases found in nature. Although
TdT was one of the first DNA polymerase activities identified in
mammals [3], it remains one of the most poorly understood enzymes
that catalyzes DNA synthesis. Indeed, the specific physiological role for
TdT remained elusive for several decades [4 11]. It is now recognized
that TdT is responsible for the random addition of nucleotides to
single stranded DNA during V(D)J recombination [12,13]. By deliber
ately generating subtle randomization of this genetic material, TdT
plays a crucial role in the evolution and adaptation of the vertebrate
immune system [6,9,14,15]. The ability of TdT to randomly incorporate
nucleotides increases antigen receptor diversity and aids in generating
the ∼1014 different immunoglobulins and ∼1018 unique T cell antigen
receptors that are required for the neutralization of potential antigens
[16,17].
This review explores the cellular and molecular mechanisms
accounting for the activity of this specialized DNA polymerase. Our
discussion begins by examining the biological role of TdT and how
synthesizing DNAwithout using a templating strand is important for V
(D)J recombination. Attention will then focus on understanding the
molecular mechanism by which TdT performs template independent
polymerization. In this section, we will compare and contrast the
mechanism of TdT with template dependent polymerases that are
involved in normal and translesion DNA synthesis, i.e., replication in
the absence of correct templating information. The reported structure
of TdT is used to provide biophysical insight into the kinetic properties
Abbreviations: TdT, terminal deoxynucleotidyl transferase; CpG, cytidine guanine
base pair; RAG-1, recombination-activating gene 1; RAG-2, recombination-activating
gene 2; RSS, recombination signal sequences; Ig, immunoglobulin; NHEJ, non-
homologous end-joining; TCR, T cell receptor; PK, protein kinase; PPi, inorganic
pyrophosphate; 5-NIMP, 5-nitro-indolyl-2′-deoxyriboside-5′-monophosphate; 5-AIMP,
5-amino-indolyl-2′-deoxyriboside-5′-monophosphate; 5-PhIMP, 5-phenyl-indolyl-2′-
deoxyriboside-5′-monophosphate; 5-CEIMP, 5-cyclohexenyl-indolyl-2′-deoxyriboside-
5′-monophosphate; TdiFs, TdTase interacting factors; PCNA, proliferating cell nuclear
antigen
1151
of the polymerase that include the utilization of various metal ion
cofactors, nucleic acids, and nucleotide substrates. Finally, the
biomedical importance of TdT will be discussed with emphasis on
its potential role in the development of certain forms of leukemia as
well as its utilization as a biochemical marker for apoptosis.
The role of TdT in V(D)J recombination
Most organisms possess sophisticated defense mechanisms to
protect them against the invasion of foreign agents such as viruses,
bacteria, and parasites. Simple prokaryotes use a complementary
system involving DNA methylation of the host genome and endonu
clease degradation of foreign genomic material to differentiate self
from non self [18]. Eukaryotes have developed more sophisticated
systems to thwart off the invasion of foreign substances. Indeed, the
mammalian immune system is arguably one of the most intricate and
ingeniousmethods for actively seeking out and killing awide variety of
invaders.
The vertebrate immune system is divided into two subcategories,
the innate and adaptive immune systems, that differ in their
specificity. The innate immune system is generally considered to be
less specific due to the promiscuous ability of the immune receptors to
recognize a limited number of molecules that are common features to
many infectious agents including polysaccharides, peptidoglycans,
non methylated CpG DNA, and double stranded RNA [19 22]. This
promiscuous activity allows the innate immune system to act as the
first line of defense against infection by rapidly recognizing and
responding to pathogens. If the defensive line of the innate system is
breached, then a more specific and highly specialized offense system,
the adaptive immune response, is mobilized to its full potential.
Adaptive immunity came into existence in vertebrates roughly
500 million years ago [23]. The cells of the adaptive immune system,
namely T and B cells, have a diverse repertoire of antigen receptors
and antibodies that can recognize any antigen encountered through
out life [24]. After the adaptive immune cell receptors bind an antigen,
they mount a rapid and robust protective response by a dramatic
expansion in the number of pathogen specific Tcells [25 28]. Over the
course of 1 week, thousands of clones are produced that possess
effector functions [29 31]. Approximately 95% of these activated Tcells
undergo apoptosis [30,32]. However, a stable population of long lived
T cells resides in the lymphoid and non lymphoid tissues [33,34] and
patrol for these previously encountered pathogens. The immunologi
cal memory displayed by the adaptive immune system provides the
vertebrate host with long lasting protection against subsequent
infection. For example, most individuals remain immune to measles
for up to 75 years once exposed to an attenuated form of measles virus
[35].
At the molecular level, the cells of the immune system have
developed a strategy to increase acquired immunity against subse
quent biological assaults [36] (Fig. 2). This process, commonly known
as V(D)J recombination, plays an essential role in abrogating these
antigens. Rearrangement of the variable (V), diversity (D) and joining
(J) gene segments creates versatility to a competent immune system
by generating a diverse repertoire of antigen receptors with unique
antibody specificities [37]. This transaction of breaking, rearranging,
and rejoiningof theV, D, and J regions of the germline immunoglobulin
genes requires the collaborative efforts of the three distinct enzyme
activities that include nucleases, polymerases, and ligases. Of the three
major types of enzymatic activities, our understanding of how specific
DNA polymerases function during V(D)J recombination is not yet
firmlyestablished. However, crucial information for understanding the
role of specific polymerases in V(D)J recombination has started to
emerge. The relative functions of the various members of the Xfamily
of DNA polymerases (TdT, pol μ, and pol λ) during the processing of
DNA in V(D)J recombination are distinct [38] and non overlapping [9]
in vivo. Ramsden et al. have indicated that a “gradient” of weak to
strong terminal deoxynucleotidyl transferase activity defines the
distinct roles of pol λ, pol μ, and TdT in non homologous end joining
(NHEJ), respectively [38]. Moreover, Bertocci et al. have shown that pol
μ participates exclusively in light chain and not in heavy chain gene
rearrangement [9,39]. In contrast, polλ is reported to be recruited only
in the heavy chain junctions during V(D)J recombination and precedes
the action of TdT [9], which is primarily involved in the random
addition of nucleotides to unpaired primer termini [38]. While pol μ
Fig. 1. Simplified models for template-dependent and template-independent DNA polymerase activity. (A) Most DNA polymerases require double-stranded DNA as a substrate,
where the 5′→3′ strand is used as a primer and the complementary strand 3′→5′ is used as a template. (B) Terminal deoxynucleotidyl transferase is unique in its ability to catalyze
phosphoryl transfer in the absence of a template that can not be accommodated in its active site.
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and polλ play important roles in the immune system, the role of TdT in
V(D)J rearrangement is showcased in this review. A more thorough
description of pol β, pol μ and pol λ is provided in a chapter by Joann
Sweasy and colleagues in this Special Issue.
Fig. 3A illustrates the crucial steps of V(D)J recombinationduring the
RAG cleavage phase. This process is initiated by introducing a double
strandbreak (DSB) at the edge of the selectedgene segment by theRAG
1 and RAG 2 (Recombination Activating Genes) proteins. These
proteins selectively bind to specific and highly conserved recombina
tion signal sequences (RSS) that contain heptamer and nonamer
elements separated by a spacer region [40,41]. There are either 12 bp or
23 bp spacers between the heptamer and nonamer elements of the RSS
commonly denoted 12 RSS or 23 RSS [40 43], respectively. Proper
recombination demands that one 12 RSS and one 23 RSS be present for
efficient cleavage in vivo [40,41,44], and this phenomenon is referred to
as the “12/23 rule”. After recognition of complementary RSS, the RAG
complex introduces a nickbetween theDand J coding segments and the
adjoining recombination signal sequence. The RAG complex also
mediates the formation of hairpins at each coding end by using the
3′ OH moiety at each nick as the nucleophile.
Double strand DNA breaks introduced during the RAG cleavage
phase are repaired during the non homologous end joining phase
(Fig. 3B). The nuclease, Artemis:DNA PKcs, can trim the 5′ and 3′
overhangs [45] and open the hairpins at the coding ends generating
palindromic nucleotide sequences (P nucleotides). At this point, TdT
randomly adds nucleotides to available 3′ OH ends increasing the
variability of the non templated nucleotide (N) region of the
recombined gene segments [46]. The details of this process are
provided in Fig. 4. While in vitro studies have shown that TdT can
incorporate all four natural nucleotides onto single stranded DNA
(vide infra), there is a definitive bias for the incorporation of dGMP
and dCMP versus dAMP or dTMP observed in vivo [8,47 50]. This
preference may offer a plausible explanation for the high G/C content
of the Ig and TCR N regions [48,49]. In addition, the average N
nucleotide segment length created in vivo is only 2 5 bp per coding
joint [47]. This length appears optimal for allowing the DNA strands to
undergo microhomology alignment using Watson Crick base pair
recognition patterns. Unpaired nucleotides are trimmed by an
exonuclease such as the Artemis:DNA PKcs complex [45]. The gaps
are ultimately filled by template dependent DNA polymerases, and
the ligation of the coding ends is carried out by the XRCC4:DNA ligase
IV complex [45].
The role of TdT in generating immunological diversity is to catalyze
the random addition of small numbers of nucleotides at the N regions.
This activity has been speculated by virtue of its catalytic properties in
addition to its localization to primary lymphoid tissues such as
thymus and bone marrow [15,51,52]. A wealth of information to
support this hypothesis exists and include the correlation between the
existence of N regions with TdT expression [13] or mRNA expression
[53] and with the inclusion of the TdT gene into a cell line that
continuously rearranges immunoglobulin genes but lacks the enzyme
[7,8]. In addition, TdT knockout mice and TdT deficient lymphocytes
[6,54] have also been used to validate the role of TdT in N nucleotide
addition during the V(D)J recombination process. As expected, TdT
knockout mice show a ten fold reduction of T cell receptor (TCR)
diversity compared to the wild type mice and provides evidence that
the addition of N nucleotides by TdT is of paramount value to
establishing a combinatorially diverse antigen receptor repertoire [54].
Biochemical properties of TdT
. Isoforms of TdT
Baltimore and colleagues were amongst the first to show that the
occurrence of short nucleotide insertions in the combinatorial
junctions of DNA segments during the V(D)J recombination process
correlates with the presence of TdT [13,55]. Over the course of several
years, different mRNA splicing variants of the enzyme were identified
and studied extensively in mice, bovines, and humans. Thus far, two
splice variants of TdT have been observed in mice while bovines and
humans each have three.
The two identified splice variants of TdT in mice are TdTS, a short
form consisting of 509 amino acids [56], and TdTL, a long form with
529 residues [57]. Both isoforms share all domains that are essential
for the binding of nucleotides, DNA, and metal ions [58,59]. However,
the 20 amino acid difference between the two variants reportedly be
stows distinct enzymatic behavior that remains controversial [60 62].
For example, Kearney et al. have shown that TdTS catalyzes the
unbiased and non templated addition of nucleotides to the combina
torial junctions of antigen receptor genes [60,62,63], while TdTL
possesses 3′→5′ exonuclease activity that can delete nucleotides at
the coding ends of the Ig and TCR gene segments [61]. In contrast,
Papanicolaou et al. have argued that TdTL does not possess exonuclease
activity and that it exhibits nearly identical enzymatic activity to TdTS
in vitro [62,64]. This discrepancy may be attributed to the lower
stability of TdTL compared to TdTS both in vitro [64] as well as in
transfected cells [60]. In addition, TdTL can reportedly modulate the
amount of nucleotide addition by TdTS [11,61]. While the mechanism
for this regulation remains undefined, these data suggest that the two
TdT murine isoforms function to balance the diversification of antigen
repertoire assembly to preserve the integrity of the variable region of
antigen receptors [61].
Human (h) and bovine (b) TdT isoforms are slightly more
complicated as each have three alternative splice variants designated
as TdTS (short), TdTL1 (long) and TdTL2 (long) [65 67]. hTdTL1 and
hTdTL2 both localize in the nucleus [67]. However, hTdTL2 is expressed
more abundantly in normal small lymphocytes compared to hTdTL1
which is readily detected in transformed lymphoid cell lines [67]. Both
long isoforms of human TdT possess 3′→5′ exonuclease activity for
nucleotide removal whereas the short isoforms perform nucleotide
Fig. 2. Overview of the V(D)J recombination process that generates functional Ig heavy chain from the inactive gene segments in developing B- or T-lymphocytes. Shown is the V(D)J
recombination process for the formation of a functional IgH gene where DJ assembly occurs prior to the combination with the V segment. See text for further details.
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Fig. 3. A simplified model for (A) the RAG cleavage phase generating double-strand breaks and (B) DNA repair through non-homologous end-joining pathway during DJ gene segment assembly of the V(D)J recombination mechanism.
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elongation of the coding ends during V(D)J recombination [65,67].
Overexpression of hTdTS or hTdTL2 independently reduces the
efficiency of V(D)J recombination greatly [67]. However, the simulta
neous overexpression of hTdTS and hTdTL2 restores recombination
frequencies back to normal levels. These observations suggest the
possibility of a strong evolutionary selection for co expressing one
transferase (hTdTS) and one exonuclease (hTdTL2) to regulate the
length of single stranded regions generated during NHEJ. In addition,
there is evidence for prohibiting the coexpression of two exonucleases
(hTdTL1 and hTdTL2) via regulation at the level of mRNA alternative
Fig. 4. Simplified overview of the enzymatic steps and the role of terminal deoxynucleotidyl transferase in lymphocyte gene rearrangement. The variability of the recombined gene
segments is increased through the random addition of non-templated (N) nucleotides catalyzed by the terminal deoxynucleotidyl transferase prior to complementary pairing and
extension by template-dependent DNA polymerases.
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splicing during V(D)J recombination [67]. In fact, the presence of all
three humanTdT variants during antigen receptor gene rearrangement
drastically diminishes recombination frequency. These results suggest
that hTdTL1 may serve to regulate hTdTL2 or hTdTS activity [67].
Sources and purification of TdT
The calf thymus glands are an abundant source of TdT. In fact, TdT
was first purified to apparent homogeneity from calf thymus cell
lysate in 1971 [68]. At first, the isolated protein was reported as a
proteolysed form containing two polypeptides originally recognized
as a heterodimer of α and β subunits [68,69]. However, subsequent
studies established that indigenous TdT is truly a monomeric protein
with a molecular weight of 58,000 to 60,000 Da [70 72]. Unfortu
nately, obtaining the enzyme in its relatively pure, intact, and active
form is extremely laborious and difficult due to proteolysis. Copious
amount of the enzyme can be purified from cultured cell lines
propagated from patients with acute lymphoblastic leukemia [73].
However, this approach is too expensive and impractical for routine
mass production of enzyme. Attempts to overexpress TdT in bacteria
systems have generally failed due to three prominent factors: (1)
mismatches in the codon frequencies and tRNA pools between E. coli
and eukaryotes, (2) low solubility of the protein in these systems, and
(3) lower levels of enzyme activity [59,74,75]. These complications
can be alleviated by overexpressing a rare argU tRNA in the E. coli
system and growing cultures at 15 °C [64,76] to boost the production
of soluble and active forms of the enzyme. Purification of TdT to
apparent homogeneity is accomplished by column chromatography
which is facilitated by the presence of a hexa histidine tag attached
to the N terminus that does not affect its activity [76]. Recombinant
human TdT has also been overexpressed in the baculovirus expres
sion system and purified to homogeneity in one step from Tricho
plusia ni larvae using a monoclonal antibody affinity column [59,74].
This last advancement has played an instrumental role in generating
significant amounts of protein required for structural characterization
of TdT.
Primer requirement
The unique activity of TdT to incorporate nucleotides in a template
independent manner was reported simultaneously by Karkow and
Kamen [77] and Bollum [78] using calf thymus extracts. The template
independent activity of TdT was distinguished from that of other
template dependent DNA polymerases by comparing levels of the
incorporation of radiolabeled nucleotides using single stranded versus
double stranded DNA [1]. Activity measured using single stranded
DNA is attributed only to that of TdT [2]. Subsequent biochemical
studies confirmed that TdTrequires a single stranded initiator that is at
least three nucleotides longwith a free 5′ phosphate end and a free 3′
hydroxyl end for extension [78]. The replication of homopolymers by
TdT requires an initiator chain of more than six nucleotides for poly
(dA) andmore than five nucleotides for poly(dT) [79]. The presence of
a ribonucleotide 5′ monophosphate (rNMP) at the 3′ end of the
primer does not inhibit the enzyme primer complex formation [80].
However, further elongation occurs at a slower rate and the addition of
more than two ribonucleotides to the single stranded initiator does
inhibit activity [80]. TdT is also unique for its ability to perform de novo
synthesis of polynucleotides ranging in size from 2 to 15 mers when
provided with dNTPs in the absence of a primer [81]. These DNA
fragments are hypothesized to act as signals for DNA repair or
recombination machinery [81]. There may indeed be credence to this
provocative hypothesis since small RNAs, designated as microRNA,
influence the activity of many biological pathways [82]. It will prove
interesting to firmly test this hypothesis to evaluate if de novo DNA
synthesis does indeed occur in vivo and that small DNA fragments can
regulate biological processes such as DNA repair and recombination.
Metal utilization
All DNA polymerases require the presence of a divalent metal ion
to catalyze the phosphoryl transfer reaction associated with nucleo
tide incorporation. The general catalytic mechanism for phosphoryl
transfer utilized by DNA polymerases is provided in Fig. 5. In this
Fig. 5. The catalytic mechanism model for the nucleotidyl transfer reaction catalyzed by terminal deoxynucleotidyl transferase. See text for details.
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mechanism, an aspartate residue near the deoxyribose sugar of the
incoming dNTP serves as the general base to abstract the proton from
the 3′ OH to generate a more reactive nucleophile. The electron rich
3′ oxygen then attacks the α phosphate creating a trigonal bipyr
amidal penta coordinated transition state. This step results in the
inversion of the α phosphate stereochemistry [83,84] and the
concerted release of the pyrophosphate leaving group coordinated
to another divalent metal ion [85 88].
TdT, like all DNA polymerases, also requires divalent metal ions for
catalysis [73,89]. However, TdT is unique in its ability to use a variety
of divalent cations such as Co2+, Mn2+, Zn2+andMg2+. In general, the
extension rate of the primer p(dA)n (where n is the chain length from
4 through 50) with dATP in the presence of divalent metal ions is
ranked in the following order: Mg2+NZn2+NCo2+NMn2+[73]. In
addition, each metal ion has different effects on the kinetics of
nucleotide incorporation. For example, Mg2+ facilitates the prefer
ential utilization of dGTP and dATP whereas Co2+ increases the
catalytic polymerization efficiency of the pyrimidines, dCTP and dTTP
[90]. Zn2+ behaves as a unique positive effector for TdT since reaction
rates with Mg2+ are stimulated by the addition of micromolar
quantities of Zn2+ [90]. This enhancement may reflect the ability of
Zn2+ to induce conformational changes in TdT that yields higher
catalytic efficiencies [90]. Polymerization rates are lower in the
presence of Mn2+ compared to Mg2+, suggesting that Mn2+ does
not support the reaction as efficiently as Mg2+ [73].
Mechanism of template-independent polymerization
When does replication without a template occur?
ADNA polymerase is classically defined as an enzyme that catalyzes
template dependent addition of mononucleotides into a growing
primer in the presence of four deoxynucleotides (dNTPs) [91]. Never
theless, many archaeal, bacterial, viral, and eukaryotic DNA poly
merases also catalyze non templated nucleotide additions to the 3′
termini of blunt ended DNA [92 96]. In addition, numerous DNA
polymerases have been demonstrated to incorporate nucleotides
opposite non instructional DNA lesions such as abasic sites via
translesion DNA synthesis [96 103]. In both of these cases, however,
these polymerases require the use of duplex DNA as a substrate for
efficient catalysis to occur. In fact, the sole polymerase that can add
nucleotides using only a single stranded DNA initiator as a substrate is
the template independent DNA polymerase, TdT [1,2]. Terminal
deoxynucleotidyl transferase activity has also been observed for pol μ
[38] and pol λ [104,105], although DNA synthesis is primarily restricted
to the use of a DNA template [38,104,105]. In the sections provided
below, we compare and contrast the mechanism of nucleotide
incorporation catalyzed by TdT with template dependent DNA poly
merases. Particular emphasis is placed on the replication of non
instructional DNA lesions as this represents the most frequent mode of
template independent DNA synthesis catalyzed by these enzymes.
Order of substrate binding
Theoretically, the binding of DNA and dNTP substrates to any DNA
polymerase can be random, sequential, or strictly ordered. Efficient
polymerization for a template dependent polymerase, however,
would be optimal through the strictly ordered binding of DNA
substrate prior to dNTP since the converse order of dNTP binding
prior to DNA would be correct only once out of four opportunities.
Indeed, numerous steady state and pre steady state studies have
validated that all template dependent polymerases obey this mechan
ism (reviewed in [106]).
Not surprisingly, TdT appears to be the lone exception to this rule.
The order by which TdT binds DNA and dNTP is indeed random as
determined through a series of initial velocity studies performed in
the absence and presence of product inhibitors [73]. The double
reciprocal plot of 1/rate versus 1/dATP concentration at several fixed
concentrations of single stranded DNA intersected to the left of the y
axis, consistent with either an ordered or random kinetic mechanism.
Inhibition by PPi at varying dNTP concentrations gave rise to a
competitive inhibition pattern whereas inhibition by PPi at different
concentrations of DNA yielded a mixed inhibition pattern. These
results are consistent with rapid equilibrium random mechanism in
which TdT forms the catalytic competent ternary complex via binding
of dNTP prior to DNA or vice versa. It is currently unclear if the ability
to randomly bind substrates plays a physiological role in generating
randomnucleotides during recombination. However, it is possible that
the interactions of TdT with PCNA and Ku70/86 [107 109], proteins
involved in replication and recombination, may influence its kinetic
mechanism.
Mechanism of nucleotide selection
An important kinetic step for generating catalytic efficiency and
fidelity with template dependent polymerases occurs during the
binding of dNTP to the polymerase:DNA complex. This process is
highly influenced by the presence of a templating strand due to
hydrogen bonding [110] and steric complementarity [111]. However,
since TdT does not rely on a templating strand for polymerization
activity, the molecular details regarding nucleotide binding and
selection remain elusive.
Several laboratories have demonstrated that TdT displays an
unequal bias in the kinetics of nucleotide incorporation. For example,
studies from the Coleman laboratory reveal that the Km for dGTP is
∼4 fold lower than the Km for dATP (compare Km values of 120 μM
versus 540 μM, respectively) [59]. Similar results are reported by the
Modak group [112]. More recently, we have demonstrated that
recombinant TdT utilizes dGTP, dCTP, and dTTP much more efficiently
than dATP [113]. The preferential use of dGTP and dCTP arguably
reflects a biophysical bias for more efficient annealing of single
stranded DNA that are intermediates during NHEJ. At the molecular
level, the preference in nucleotide utilization could reflect favorable
hydrogen bonding interactions between the incoming dNTP and
active site amino acids that guide nucleotide binding. This mechanism
would resemble that displayed by the yeast Rev1 protein, an error
prone DNA polymerase that preferentially incorporates dCMP via
direct interactions with an active site arginine as opposed to
interactions with the templating base [114]. The discrimination
against the utilization of dATP is also intriguing especially when
compared to the preferential incorporation of dAMP by high fidelity
DNA polymerases during the replication of non coding DNA lesions
such as abasic sites. Template dependent DNA polymerases such as
the E. coli Klenow fragment [101] and bacteriophage T4 polymerase
[101,103] incorporate dAMP opposite an abasic site ∼100 fold more
efficiently than any of the other three natural nucleotides. The
preferential incorporation of dAMP by these high fidelity DNA
polymerases is often referred to as the “A rule” of translesion DNA
synthesis [115]. Thus, the preferential usage of dGTP and dCTP by TdT
indicates that it does not follow the “A rule” like the aforementioned
well characterized template dependent DNA polymerases.
It is also interesting that TdT efficiently incorporates and extends a
wide variety of 5 substituted indolyl deoxynucleotides that lack
hydrogen bonding functional groups (Fig. 6). TdT uses non natural
nucleotides such as 5 NITP with identical efficiencies as dGTP, the
preferred natural nucleotide [113]. This result is intriguing since 5
NITP has been used as a chemical probe to validate the “A rule” of
translesion DNA synthesis with template dependent DNA poly
merases [101]. In fact, several template dependent polymerases
incorporate 5 NIMP opposite an abasic site with remarkably high
catalytic efficiencies that approach 106 M−1s−1 [116]. Thus, TdT
presents an interesting paradox by its ability to discriminate against
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inserting dATP yet effectively incorporating non natural nucleotides
that are used as mechanistic probes for the “A rule” of translesion
DNA synthesis.
A naive mechanism to explain the utilization of these non natural
nucleotides is that the primary molecular determinant for nucleotide
binding resides simply with interactions of the negatively charged
triphosphate moieties with positively charged amino acids in the
polymerase's active site. This is unlikely to be the sole source for
binding as it cannot account for the significant differences observed
for the incorporation of various natural and non natural nucleotide
substrates. For example, 5 NIMP is incorporated and extended 10 fold
more efficiently than the closely related analog, 5 AIMP, which is
poorly incorporated even at concentrations greater than 500 μM [113].
In addition, the replacement of an active site arginine residue (R336)
involved in binding the triphosphate moiety of a dNTP with either
glutamine (R336Q) or alanine (R336A) does not completely abolish
nucleotide binding. Instead, these amino acid substitutions reduce the
binding affinities of dGTP and dATP by only 10 fold [59]. These data
indicate that ionic interactions between the active site arginine and
the triphosphate group are important but not essential for nucleotide
binding.
A final point to discuss is with respect to the kinetics of elongation.
Our studies with the various 5 substituted indolyl deoxynucleotides
provided in Fig. 6 reveal an inverse correlation in the kinetics of
primer elongation as a function of nucleobase size [113]. For example,
large analogs such as 5 PhIMP, 5 CEIMP, and 5 NapIMP are incorpo
rated but not efficiently elongated whereas their smaller counterparts
(IndMP, 5 FIMP, and 5 NIMP) are elongated with similar efficiency as
natural nucleotides [113]. The inability of TdT to elongate bulky non
natural nucleotides likely results from the steric constraints imposed
by the 16 amino acid loop present within TdT (see below) that
appears to function as a steric gate to provide selectivity for single
stranded versus duplex DNA.
What limits nucleotide incorporation?
After nucleotide binding, most DNA polymerases undergo an
enzymatic conformational change that is proposed to align the
incoming dNTP into a precise geometrical shape with the templating
nucleobase to allow for phosphoryl transfer. The existence of this
conformational change has been demonstrated through kinetic,
structural, and spectroscopic studies [93,98,117 121] and the reader
is recommended to read the article by Kenneth Johnson (this issue)
for further details on this subject. Regardless, this conformational
change step is believed to impose discrimination against misinserting
an incorrect nucleotide into DNA by altering the geometry of the
polymerase's active site to inhibit efficient phosphoryl transfer [122].
Since TdT uses only single stranded DNA [1,2], the need for an
obligatory conformational change step to ensure fidelity remains in
doubt. Put another way, does the lack of “fidelity” displayed by TdT
negate the need for a conformational change step? If so, does
phosphoryl transfer then become the rate limiting step for nucleotide
incorporation as similarly reported for certain “error prone” poly
merases that have lower constraints in fidelity [123,124]? Indeed, it is
established that with certain DNA polymerases such as pol β, the
phosphoryl transfer step as opposed to a conformational change is
involved in maintaining fidelity during the nucleotide incorporation
step [125].
One way to evaluate the location of the rate limiting step during
polymerization is to measure the effects of thio substituted nucleo
tides on the rate of nucleotide incorporation [126]. Since a non
bridging sulfur atom has decreased electronegativity, it is predicted to
be less effective than oxygen at stabilizing electron density during the
transition state of phosphoryl transfer. As a result, the magnitude of a
“thio effect”, defined as the rate of incorporation using α O dNTP
versus the rate using an identical concentration of α S dNTP, can be
used as a diagnostic indication of whether or not chemistry is rate
limiting. If chemistry is the rate limiting step, then a significant thio
elemental effect (N10) is typically observed while smaller thio
elemental effects ofb2 are observed if another kinetic step such as a
conformational change preceding phosphoryl transfer is rate limiting,
and thus insensitive to thio substitution. We have preliminary data
defining the elemental effect for the incorporation of α S dGMP by
TdT using different metal cofactors. With Co2+ as the metal cofactor,
the rate of α S dGTP incorporation is 8 fold slower than that
measured using an identical concentration of α O dGTP (unpublished
results, Berdis, A.J.). The apparent elemental effect of 8 suggests that
phosphoryl transfer is indeed the rate limiting step and is consistent
with structural data indicating that TdT exists in a “closed”
conformation that alleviates the need for a conformational change
for catalysis to occur [127]. In contrast, replacement of Co2+withMg2+
gives rise to a smaller elemental effect of ∼3 (unpublished results,
Fig. 6. Chemical structures of various 5-substituted indolyl nucleotides used to probe the activity of TdT.
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Berdis, A.J.). The change in the magnitude of the elemental effects
suggests that phosphoryl transfer is no longer rate limiting using
Mg2+ as the metal cofactor. One implication of these findings is that
metal ions directly influence themechanism of template independent
polymerization by changing the location of the rate limiting step.
However, controversy exists regarding the use of thio elemental effect
to unambiguously define the rate limiting step for nucleotide
incorporation. Much of this controversy involves potential differences
in the transition states between the enzyme catalyzed and non
enzymatic reaction [128].Therefore, further kinetic and spectroscopic
studies on TdT are needed to further investigate this phenomenon.
Distributive versus processive DNA synthesis
After nucleotide incorporation, template dependent polymerases
show an obligatory release of products in which pyrophosphate is the
first product released. At this point, the polymerase can either remain
bound to DNA and continue primer elongation or dissociate from the
extended primer to re initiate DNA synthesis on another usable
primer. Since TdT functions via a rapid equilibrium random kinetic
mechanism [73], it is most likely that TdT catalyzes DNA synthesis in a
strictly distributive mode. While this mechanism is reasonable, it has
yet to be conclusively established.
Structural insights into the mechanism of TdT
The X family of DNA polymerases
TdT is a member of the X family of DNA polymerases that include
DNA polymerase β, (pol β), DNA polymerase λ (pol λ), and DNA
polymerase μ (pol μ). Pol β removes the 5′ deoxyribose phosphate
moiety and catalyzes gap filling synthesis during base excision repair.
The mechanism of this polymerase is described in a chapter by Joann
Sweasy and colleagues provided in this Special Issue. Pol λ is proposed
to have multiple cellular activities. The primary biological role of pol λ
is to repair double stranded breaks (DSBs) and is based upon results
showing that recombination does not occur in cell extracts that have
been immunodepleted for pol λ [129]. Pol λ has also been
demonstrated to perform template independent DNA synthesis
using single stranded DNA or partially double stranded DNA with a
short 3′ overhang [105]. Finally, pol λ is also believed to be an error
prone DNA polymerase since it can bypass certain DNA lesions
including abasic sites [130]. However, the physiological role of pol λ in
performing translesion DNA synthesis has yet to be validated in vivo.
In contrast, pol μ is a bona fide error prone DNA polymerase that plays
an active role in somatic hypermutation [131]. This activity is based on
the preferential expression of pol μ in secondary lymphoid tissues as
well as its low fidelity during the replication of undamaged DNA [132].
Additionally, the ability of pol μ to bypass several DNA lesions through
a deletion mechanism provides circumstantial evidence for its role as
a mutase during somatic hypermutation [133]. A perspective on the
role of certain X family DNA polymerases in regulating nucleic acid
integrity is provided in a recent review by Ramadan et al. [134].
Features of TdT common with other X family polymerases
Sequence alignment of the C termini of the X family DNA
polymerases reveals that all these enzymes possess the fingers,
palm, and thumb subdomains that are similar to those described first
for pol β (Fig. 7). TdT, pol λ, and pol μ contain nuclear localization
signal motifs as well as breast cancer susceptibility protein BRCA1 C
terminal (BRCT) domains in their N termini [127]. BRCT domains
function to mediate protein/protein and protein/DNA interactions in
DNA repair and cell cycle check point pathways that are activated by
DNA damage [135]. As described later in this review, the BRCT domain
of TdT, pol λ, and pol μ may interact with Ku70/80, a heterodimeric
protein involved in recognizing and binding the ends of double strand
DNA breaks formed during V(D)J recombination.
Considering this information, it is quite surprising that members of
this family show little primary amino acid sequence identity. For
instance, TdT and pol μ share only 42% amino acid identity yet are
considered the most closely related members of the X family of
polymerases [136]. Despite this low identity, it is proposed that TdT
and pol μ arose from a common ancestor that was a template
dependent polymerase [137]. The strict template independent activ
ity of TdTappears to be a recent evolutionary event that coincideswith
the development of V(D)J recombination in mammals.
Tertiary structure of TdT
All template dependent DNA polymerases characterized to date by
structural methods show an overall molecular architecture that is
analogous to a right hand containing thumb, fingers, and palm
subdomains (Fig. 8, inset 1) (reviewed in [86]). Although these
subdomains work synergistically during the polymerization process, it
is easier to describe their functions independently. The palm
subdomain is considered to be the heart of the polymerase as this is
where the phosphoryl transfer reaction takes place. This subdomain
contains at least two carboxylate residues that are highly conserved
amongst all DNA polymerases [138] which function to coordinate
metal ions that act as Lewis acids. These metal ions lower the
activation energy barrier for the phosphoryl transfer reaction by
stabilizing the build up of the negative charge that accumulates on
the α phosphate and the oxyanion of the β and γ phosphate leaving
group of the incoming dNTP substrate [88]. The function of the fingers
subdomain is to coordinate interactions between the templating base
and the incoming dNTP. These interactions are designed to align the
nucleobases properly prior to catalysis. With template dependent
DNA polymerases such as pol β [87,139,140], the thumb subdomain
serves a dual role by positioning duplex DNA for accepting the
incoming dNTP as well as for translocation of the polymerase to the
next templating base position after catalysis.
Fig. 7. Schematic representations of the different domains found in the four X-family DNA polymerases. Each domain is labeled and colored for clarity. NLS represents the nuclear
localization signal motif, and BRCT indicates the BRCA1 carboxy terminus domain.
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Fig. 8. Crystal structure of terminal deoxynucleotidyl transferase showing the finger, thumb, palm and index finger (8 kDa) subdomains that work synergistically to catalyze
nucleotide incorporation. Inset 1 shows the hand-like morphology of most DNA polymerases. Inset 2 shows a surface model for the ring-like structure of TdT in which the primer
strand is located perpendicular to the hole where dNTPs presumably diffuse to enter the active site. The ternary complex structure was prepared using the available binary crystal
structures of murine TdT (PDB ID codes 1KEJ (TdT·ddATP) and 1KDH (TdT·ssDNA) [116]). MOE (www.chemcomp.com) was used for all structural modeling.
Fig. 9. The active site of TdT (PDB ID code: 1KEJ) as defined by amino acids that exist within 6 Å of the bound nucleotide substrate, ddATP. The incoming nucleotide is shown in ball-
stick representation in CPK color scheme. The two cobalt ions are colored as cyan. This figure was prepared using the UCSF Chimera package (http://www.cgl.ucsf.edu/chimera).
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The structure of TdT shown in Fig. 8 shows similarities to template
dependent DNA polymerases by the presence of thumb, fingers, and
palm subdomains. The catalytic site of TdT also shows the presence of
two Co2+ ions in the palmdomain [127]. This feature is consistentwith
the proposed “twodivalentmetal ion”mechanism [88] associatedwith
all polymerases currently identified. Finally, these metal ions are
coordinated by the oxygen atoms of the triphosphate moiety of the
incoming dNTP as well as by three aspartate residues [127].
Despite these similarities, there are some notable structural
variations in TdT that distinguish it from template dependent
polymerases. In particular, TdT possesses a “lariat like” loop that
prevents the enzyme from interacting with a template strand [127]. In
addition, TdT contains an 8 kDa domain, also known as the “index
finger” domain, which contacts the thumb subdomain to form a hole
that may allow dNTPs to diffuse into the enzyme's active site [127].
This feature defines the general morphology of TdT as a ring like
structure in which the primer lies perpendicularly to the axis of the
hole on the palm domain (Fig. 8, inset 2).
Superimposing the structure of TdT (PDB ID code 1KEJ) [127] with
the closed form of pol λ (PDB ID code 1XSN) [141] shows that the
“lariat like” loop of 16 amino acids in TdT crystal structure prevents
the polymerase from interacting with duplex DNA (Fig. 9). This
provides a physical explanation for the unique ability of TdT to
catalyze the nucleotidyl transfer reaction in a template independent
fashion. Delarue et al. originally pointed out that TdT appears to be
sealed in a closed conformation that is similar to pol β [127],
Fig. 10. Comparing the crystal structures of template-independent TdT enzyme (PDB code: 1KEJ) and template-dependent DNA polymerase, pol λ (PDB code: 1XSN). (A)
Superimposed structures of TdT and pol λ. The superimposed structures show an incredibly high degree of similarity between the two polymerases of the family X despite the fact
that they catalyze different modes of DNA polymerization (template-independent versus template-dependent). (B) The ribbon structure of TdT (left) with the putative model of
primer-template duplex derived from the human pol λ ternary complex (right) to show the “lariat-like” loop (in magenta) that prevents the ability of TdT to accommodate a
templating strand. (C) Molecular surface model of TdT (left) with the putative model of primer-template duplex (shown in ribbon) derived from the human pol λ ternary complex
(right). The dNTP is shown in ball and stick model in CPK color scheme. The models were prepared using the MOE package (www.chemcomp.com).
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suggesting that TdT can add nucleotides without undergoing an
obligatory conformational change [127].
Insight into the mechanism of nucleotide selection comes from an
examination of the available binary structures of the TdT·ddATP (PDB
ID code 1KEJ) and TdT·ssDNA (PDB ID code 1KDH) complexes [127].
An inspection of amino acids that reside within 6 Å of the bound
ddATP (Fig. 10) reveals the presence of three positively charged
residues (Lys338, Arg336, and Arg454) that point toward the tripho
sphate moiety to neutralize the negatively charged phosphate
molecules. In addition, three conserved aspartates (Asp343, Asp345,
and Asp434) reside in the catalytic palm subdomain and function to
position two Co2+ ions for catalysis. The aromatic ring of Trp450
appears to provide favorable pi pi stacking interaction as it lies
parallel to the adenine ring of the incoming nucleotide and resides
only 3.6 Å away. The positively charged ɛ amino group of Lys403 side
chain is only 4 Å away and can provide favorable pi cation
interactions with the adenine nucleobase. Although Arg454 interacts
with the triphosphate moiety, it may also participate in pi cation
interactions with the aromatic adenine to provide additional stability.
No other side chains are in close proximity with either the 2′ or the 3′
position of the sugar of ddATP. The absence of amino acids that could
function as a “steric gate” could account for the rather promiscuous
nature of TdT in its ability to incorporate both ribo and deoxyr
ibonucleotides [142].
Regulating the activity of TdT
Since V(D)J recombination is required for a competent immune
system, it is imperative that the activities of the enzymes involved in
this process be tightly regulated. TdT is no exception as it is regulated
by transcriptional control, post translational modifications, and
protein protein interactions [143].
Expression of TdT is confined to primary lymphoid tissues
including thymus and bonemarrow [15,51,52]. Transcriptional control
is regulated by proteins such as AP 1 [144] as well as through the
expression of the RAG genes [145]. The activity of TdT may also be
regulated at the post translational level by phosphorylation. It has
been demonstrated that TdT is phosphorylated in lymphoblastoid
cells when treated with [32P] phosphate [146]. In addition, recombi
nant human TdT is phosphorylated in vitro by protein kinase C [147]
while calf thymus TdT can be phosphorylated by beef heart cAMP
dependent protein kinase [148]. In the latter case, calf thymus TdT is
phosphorylated at multiple sites that correspond to amino acids Ser7
and Thr19 in human TdT [74,146]. While TdT can be phosphorylated at
multiple sites, it is unclear as to how phosphorylation regulates its
activity in vivo.
Protein protein interactions between TdT and other DNA binding
proteins have been shown to produce both positive and negative
effects on the catalytic activity of TdT [108,149]. One group of proteins
reported to regulate the activity of TdT are referred to as TdT
interacting factors (TdiFs). TdiF1 is a protein that binds to the C
terminus of TdTand increases its polymerase activity by∼4 fold [108].
TdiF2 is another protein that binds TdT through its C terminus,
possibly through interactions with the proline rich and pol β like
domains. However, the interaction of TdiF2 with TdT decreases the
polymerase activity of TdT by ∼2 fold [108].
PCNA is another protein that physically interacts with TdT [146]. By
encircling DNA, PCNA acts as a general processivity factor for various
template dependent DNA polymerases including pol δ and ɛ [150]. In
fact, PCNA orchestrates nearly every aspect of DNA synthesis ranging
from chromosomal DNA replication to DNA repair and recombination
[151]. PCNA decreases the polymerase activity of TdT by ∼2 fold. This
effect on TdT activity is similar to that observed by TdiF2 [146]. One
possibility is that PCNA and TdiF2 compete with TdiF1 for binding to
the C terminus of TdT which provides a mechanism to reversibly
regulate TdT activity.
Other proteins such as the Ku proteins and template dependent
DNA polymerases may also regulate the activity of TdT. For example,
the “N” regions generated by TdT are unusually longer when Ku80 is
knocked out compared to when it is normally expressed [152]. Since
Ku80 aids in the recruitment of TdT to the site of V(D)J recombination,
these knock down experiments suggests that Ku80 also regulates the
catalytic activity of TdT once it is bound to DNA [61,153]. TdT activity
can also be regulated indirectly by other members of the X family of
polymerases. For example, TdT and Pol μ can efficiently compete for
the same DNA substrate [152]. It has subsequently been argued that
both proteins, if present during V(D)J recombination, could compete
for DNA ends such that Pol μ could affect the activity of TdT during “N”
region synthesis [132].
Biomedical applications of TdT
TdT as an anti cancer target
There is mounting clinical evidence that alterations in TdT activity
and/or its level of expression play significant roles in cancer initiation,
progression, and response to chemotherapy. TdT is overexpressed in
B and T cell acute lymphocytic leukemias (ALL) and in acute
myelocytic leukemias (AML) [154 156]. About 90% of patients with
ALL show variable levels of TdTexpression aswell asmultiple isoforms
of TdT in their blast cells [154 156]. While the frequency of TdT
overexpression in AML is less (∼20%), it is still significantly higher
than levels found in lymphoid malignancies such as chronic
lymphocytic leukemia (CLL) [156]. In addition, higher levels of TdT
activity correlate with a poor prognosis due to sub optimal responses
to chemotherapy that culminates in reduced survival times. Prognosis
and survival studies show that remission rates are two fold lower in
leukemia patients that are TdT positive compared to TdT negative
patients [157]. These findings have driven attempts to develop
selective inhibitors against TdT that could be employed as chemother
apeutic agents against these forms of leukemia. One example is the
nucleoside analog cordycepin (3′ deoxy adenosine) (Fig. 11A). This
nucleoside analog is cytotoxic against TdT positive leukemias,
especially when used in combination with the adenosine deaminase
inhibitor deoxycoformycin [158,159]. The cytotoxic activity of cordy
cepin correlates with the ability of the triphosphate form to inhibit
single stranded DNA synthesis by TdT in vitro [160]. Since cordycepin
lacks a 3′ OH moiety, incorporation of this analog terminates primer
extension and generates abortive intermediates along the recombina
tion pathway that may induce apoptosis.
Unfortunately, cordycepin is not widely used in chemotherapy as it
causes side effects that are associated with the inhibition of various
enzymes involved in nucleos(t)ide metabolism [161]. As a conse
quence, there is significant effort in developing selectively inhibitors
of TdT that do not resemble nucleos(t)ide analogs. Indeed, encoura
ging progress has been made by the groups of DiSanto and Maga as
evident in their recent demonstration that certain aryldiketo hexenoic
acids inhibit the catalytic activity of pol λ and TdT without acting as
chain terminators [162]. One analog, designated RDS 2119 (Fig. 11B),
displays higher cytotoxicity against a TdT positive leukemia cell line
(Molt4) compared to a cell line derived from cervical cancer (HeLa)
[162].
TdT as a biochemical tool
TdT utilizes a wide variety of nucleotide analogs such as 2′,3′
dideoxynucleotides [163], p nitrophenylethyl triphosphate [164], p
nitrophenyl triphosphate [164], 2′ deoxy L ribonucleoside 5′ tripho
sphates [165], and dinucleoside 5′,5′ tetraphosphates [166]. The
ability of TdT to tolerate bulky modifications to the nucleobase moeity
has led to an effective method for in vivo and in vitro labeling of
double strand DNA breaks. One technique called TUNEL (TdT
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mediated dUTP biotin nick end labeling) is based on the ability of TdT
to efficiently incorporate biotinylated dUMP on to 3′ ends of single
stranded DNA that occur at the sites of DNA breaks. The incorporated
biotin dUMP is easily visualized by fluorescently labeled avidin or
streptavidin and allows for direct conformation and quantitative
measurements of the number and location of DNA breaks. This
technology is widely used for the detection of apoptosis, a form of
programmed cell death in eukaryotic cells [167]. In addition, TdT can
be used as a biocatalyst to label the 3′ termini of synthetic
oligonucleotides with a radioactive nucleotide or a variety of
fluorescent probes [168]. These labeled primers can then be annealed
to a complementary strand and used as radioactive substrates to
monitor the activity of enzymes involved in nucleic acid metabolism
that include restriction endonucleases, DNA glycosylases, and tem
plate dependent DNA polymerases.
Conclusions
Amongst all DNA polymerases identified to date, TdT remains the
most enigmatic. This remarkable polymerase can truly be called the
“black sheep” of the polymerase family since it breaks (or at least
bends) nearly every rule established for template dependent poly
merases. Most notably, TdT is defiant in its inability to perform
polymerization with duplex DNA while incorporating nucleotides
using single stranded DNA as the substrate. The template indepen
dent activity of TdT predicts that it should incorporate natural dNMPs
with equal efficiencies. Again, TdT bends the rules by displaying an
unexplained bias towards incorporating dGMP and dCMP. In fact, TdT
even discriminates against the incorporation of dAMP, the preferred
nucleotide for template dependent polymerase during the replication
of certain forms of damaged DNA. Finally, TdT is unique in its ability to
randomly bind DNA and dNTP to form the catalytically competent
ternary complex. It could be argued that TdT must be rebellious in
order to perform its unique biological function for generating random
coding information during V(D)J recombination.
Although TdT is unique, it does share many features that are
common amongst most template dependent DNA polymerases. From a
structural perspective, TdT contains the fingers, thumb, and palm
subdomains that are present in all DNA polymerases characterized to
date. Themost notable difference is the inclusionof the “lariat loop” that
blocks the ability of TdT to utilize duplex DNA. Furthermore, TdT can
interact with other replicative proteins such as PCNA that function to
coordinate polymerase activity during replication, repair, and recombi
nation. Although the functional outcome of these interactions remain
poorly understood, future biochemical and cell based studies will
undoubtedly shed more insight into the biological role and molecular
mechanism of this fascinating and enigmatic DNA polymerase.
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